argenx NV ADR (ARGX) Stock Analysis

argenx NV ADR (ARGX) is a publicly traded company in the HEALTHCARE sector. It trades at $802.17, carries a market capitalization of $52.25B, a price-to-earnings ratio of 37.08. This page summarizes the public market data, fundamentals, and frequently asked questions for ARGX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $802.17
• Market Cap: $52.25B
• P/E Ratio: 37.08
• EPS: $22.55
• 52-Week High: $934.62
• 52-Week Low: $510.06

Market Sentiment

argenx NV ADR currently has a Bullish sentiment score of 0.33.

GNG Research Analysis

GNG Research scores argenx NV ADR (ARGX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ARGX.

Frequently Asked Questions

Does ARGX pay dividends?

argenx NV ADR (ARGX) does not currently pay a regular dividend.

What is ARGX's P/E ratio?

argenx NV ADR has a price-to-earnings (P/E) ratio of 37.08.

What is ARGX's market cap?

argenx NV ADR (ARGX) has a market capitalization of $52.25B with a current stock price of $802.17.